FIELD: medicine.
SUBSTANCE: method involves determining a period of time from the onset of symptoms to establishing a diagnosis (t); a functional class is rated at the time of establishing the diagnosis (FCinit); a cardiac output is calculated at the time of establishing the diagnosis (CO); an acute pharmacological test (APT) coefficient (X) is calculated as follows: (APT-)=0, (APT+)=1, (APT++)=2. A risk of the unfavourable clinical outcome in the patients suffering from idiopathic pulmonary hypertension (H) is calculated by an original formula. If the value H ≤0.35, a low risk is stated; H=0.36-0.55 shows a moderate risk, whereas H≥0.56 is a sign of a high risk of the unfavourable clinical outcome.
EFFECT: method enables the high-reliability detection of the unfavourable clinical outcome in the patients with idiopathic pulmonary hypertension, the determination of rates of the disease progression for the purpose of prescribing an adequate therapy.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SELECTING DRUG THERAPY FOR PATIENTS WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION | 2014 |
|
RU2559424C1 |
EVALUATION PROCEDURE OF OPERABILITY IN CHILDREN SUFFERING FROM CONGENITAL HEART DISEASES COMPLICATED BY HIGH PULMONARY HYPERTENSION | 2008 |
|
RU2354304C1 |
METHOD FOR PREDICTING THE FLOW OF PULMONARY HYPERTENSION IN PATIENTS WITH INBORN HEART FAILURES | 2004 |
|
RU2281033C2 |
METHOD FOR ASSESSING THE SEVERITY OF THE PATIENTS WITH IDIOPATHIC AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION BY THE PULMONARY ARTERY ELASTIC PROPERTIES | 2019 |
|
RU2723360C1 |
METHOD FOR EVALUATING THE UNFAVORABLE COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION WHEN COMBINED | 2018 |
|
RU2711453C1 |
METHOD OF PREDICTING PROBABLE LETHAL OUTCOME IN PATIENTS WITH LIVER CIRRHOSIS OF VIRAL, ALCOHOL AND COMBINED ETIOLOGY IN COMBINATION WITH PULMONARY HYPERTENSION | 2009 |
|
RU2398506C1 |
METHOD FOR PREDICTING THE SEVERITY OF IDIOPATHIC PULMONARY HYPERTENSION | 2021 |
|
RU2770820C1 |
METHOD FOR PREDICTING THE ONE-YEAR RISK OF ADVERSE CARDIOVASCULAR EVENTS IN MEN AFTER DECOMPENSATION OF CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION AND OBSTRUCTIVE SLEEP APNEA SYNDROME | 2021 |
|
RU2767266C1 |
METHOD FOR PREDICTING DEVELOPMENT OF CARDIOVASCULAR COMPLICATIONS IN THE LATE PERIOD AFTER ACUTE CORONARY SYNDROME | 2017 |
|
RU2663935C1 |
METHOD OF PREDICTING THE EFFECTIVENESS OF PROLONGED SPECIFIC THERAPY IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION AND INOPERABLE CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION | 2020 |
|
RU2729033C1 |
Authors
Dates
2015-07-10—Published
2014-05-29—Filed